The estimated glomerular filtration rate (eGFR) is a blood test to assess kidney function. The formula for calculating eGFR takes the patient’s body size, age, and sex into account to predict ...

A blood sample is ready for estimated glomerular filtration rate, or eGFR, testing. Current eGFR tests use race as a variable, but NIH-funded research suggests using an alternative biomarker in ...

Kidney disease can be symptomless in early stages, but signs like fatigue, swelling, changes in urine, shortness of breath, ...

An EGFR gene mutation is one of the biomarkers a doctor often tests for after confirming a diagnosis of non-small cell lung cancer (NSCLC). Biomarkers can help guide treatment. EGFR mutations ...

Diabetes, hypertension, and kidney disease are three conditions which at first glance, may not seem connected. However, when ...

approved the first blood test for the EGFR mutation in NSCLC. This test, also known as a liquid biopsy, can help provide an accurate diagnosis if getting a tissue sample is difficult. Treatment ...

Extracting a venous blood sample and delivering it to a lab for creatinine/eGFR testing may delay chemotherapy for many hours. A chemotherapy treatment that may take only a few hours could take an ...

Routine use of tolvaptan in clinical practice may slow eGFR decline for patients with autosomal dominant polycystic kidney ...

Objective Many societies recommend using estimated glomerular filtration rate (eGFR) rather than serum creatinine (sCr) to determine metformin eligibility. We examined the potential impact of ...